These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 12230692)
21. [Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination]. Uhnoo I; Linde A Lakartidningen; 2005 Dec 5-11; 102(49):3802-3, 3805-6, 3808. PubMed ID: 16408704 [TBL] [Abstract][Full Text] [Related]
22. Zanamivir in the prevention of influenza among healthy adults. Bower DJ; Slawson JG J Fam Pract; 1999 Oct; 48(10):748. PubMed ID: 12224667 [No Abstract] [Full Text] [Related]
23. [Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically]. Kaji M Nihon Rinsho; 2003 Nov; 61(11):1975-9. PubMed ID: 14619441 [TBL] [Abstract][Full Text] [Related]
26. [Influenza prevention in your practice (interview by Waldtraud Paukstadt)]. Buchholz U MMW Fortschr Med; 2005 Nov; 147(46):10. PubMed ID: 16358627 [No Abstract] [Full Text] [Related]
27. [Efficacy of inhaled zanamivir in the treatment and prevention of influenza]. Abad-Santos F; Gallego Sandín S; Novalbos Reina J; Martínez Sancho E; Gálvez Múgica MA An Med Interna; 2001 Feb; 18(2):93-9. PubMed ID: 11322008 [TBL] [Abstract][Full Text] [Related]
29. Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors. Cross J; Wedekind CA Med Health R I; 2001 Jun; 84(6):209-11. PubMed ID: 11434154 [No Abstract] [Full Text] [Related]
30. [English meta-analysis on zanamivir and oseltamivir. Knowledge of effects of influenza agents still not sufficient]. Liedholm H Lakartidningen; 2003 Dec; 100(50):4186-9. PubMed ID: 14717007 [No Abstract] [Full Text] [Related]
31. Oseltamivir: new preparation. An antiviral agent with little impact on influenza. Prescrire Int; 2003 Jun; 12(65):85-8. PubMed ID: 12825569 [TBL] [Abstract][Full Text] [Related]
32. [New flu therapy. Progress or burden for the budget?]. Vogel GE MMW Fortschr Med; 2000 Feb; 142(8):14. PubMed ID: 10810861 [No Abstract] [Full Text] [Related]
33. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Uyeki TM Pediatr Infect Dis J; 2003 Feb; 22(2):164-77. PubMed ID: 12586981 [TBL] [Abstract][Full Text] [Related]
34. Neuraminidase inhibitors for treatment of influenza A and B infections. MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443 [TBL] [Abstract][Full Text] [Related]
36. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE; J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262 [TBL] [Abstract][Full Text] [Related]
37. [New preparations against influenza]. Westergren T Tidsskr Nor Laegeforen; 2001 Feb; 121(4):466-7. PubMed ID: 11255865 [No Abstract] [Full Text] [Related]
38. New influenza drugs zanamivir (Relenza) and oseltamivir (Tamiflu): unexpected serious reactions. Macdonald L CMAJ; 2000 Oct; 163(7):879-81, 883-5. PubMed ID: 11033723 [No Abstract] [Full Text] [Related]
39. Summaries for patients. Influenza vaccination or antiviral treatment for healthy working adults: an economic analysis. Ann Intern Med; 2002 Aug; 137(4):I22. PubMed ID: 12186536 [No Abstract] [Full Text] [Related]